About
Sarah Meibusch is Partner and Head of Healthcare at OneVentures, bringing over 20 years of enterprise-level business leadership across science and technology sectors in both for-profit and not-for-profit organizations. Her experience includes negotiating corporate transactions, research partnerships, licensing agreements, and mergers and acquisitions across corporate, government, and university environments, as well as managing corporate actions for NASDAQ and ASX-listed companies. She has held roles at organizations including Vaxxas, BiVACOR, Shire Pharmaceuticals, and the University of Queensland.
Contact· self-published, not guessed
Experience
- OneVenturesPartner, Head of Healthcarecurrent2025 — present
- OneVenturesPartnercurrent2022 — present
- OneVenturesPrincipal2019 — 2022
- OneVenturesInvestment Manager2017 — 2018
- VaxxasChair of the Board of Directorscurrent2025 — present
- VaxxasBoard Alternate Director and Observer2020 — 2025
- Vertero Therapeutics, Inc.Non Executive Directorcurrent2021 — present
- Vertero Therapeutics, Inc.Chair of the Board of Directors2023 — 2025
- Kira Biotech Pty LtdNon Executive Directorcurrent2020 — present
- Kira Biotech Pty LtdNonexecutive Director - Chair of the Board2019 — 2020
- PROTA THERAPEUTICS PTY LTDBoard Alternate Director and Observercurrent2019 — present
- BearTrap Solutions Pty LtdPrincipalcurrent2009 — present
- Life Sciences Queensland LimitedNonexecutive Director2019 — 2025
- Queensland Alliance for Agriculture and Food Innovation (QAAFI)Member Of The Board Of Advisors2017 — 2024
- Queensland Alliance for Agriculture and Food Innovation (QAAFI)Deputy Director2012 — 2017
- Blade TherapeuticsBoard Observer2019 — 2023
- Paragen BioBoard Observer2018 — 2020
- Shire PharmaceuticalsContractor - Asia Business Development2011 — 2016
- Cooperative Research Centre for Beef Genetic Technologies (Beef CRC)Chief Operating Officer, Commercialisation2009 — 2012
- The Australian VoicesNon Executive Director2011
- Progen PharmaceuticalsVice President of Business Development2003 — 2009
- Pyxis GenomicsManager of Business Development2001 — 2003
Skills & more
Strategy49Strategic Planning20Management12Biotechnology84Commercialization60Pharmaceutical Industry37Life Sciences35Technology Transfer27Lifesciences27Start-ups21Business Development19Biopharmaceuticals14
+12 more
OncologyDrug DevelopmentLicensingBusiness StrategyDrug DiscoveryMergers & AcquisitionsClinical DevelopmentCorporate DevelopmentGenomicsR&DRegulatory AffairsFDALanguages English · German
From Sarah's professional profile.
Colleagues at OneVentures
Anne-Marie Birkill
Investor at OneVentures
Bevin Shields
Partner at OneVentures
Jay Chiu
Investment Director at OneVentures
Justine Carzino
Investment Director at OneVentures
Kate Madden
Investment Director at OneVentures
Lu Li
Investment Analyst at OneVentures
Michelle Deaker
Founding Partner and Managing Director at OneVentures
Nick Gainsley
Partner at OneVentures
Frequently asked questions
- Who is Sarah Meibusch?
- Sarah Meibusch is Partner and Head of Healthcare at OneVentures, bringing over 20 years of enterprise-level business leadership across science and technology sectors in both for-profit and not-for-profit organizations. Her experience includes negotiating corporate transactions, research partnerships, licensing agreements, and mergers and acquisitions across corporate, government, and university environments, as well as managing corporate actions for NASDAQ and ASX-listed companies. She has held roles at organizations including Vaxxas, BiVACOR, Shire Pharmaceuticals, and the University of Queensland.
- Where does Sarah Meibusch work?
- Sarah Meibusch is Partner at OneVentures.
- Where did Sarah Meibusch go to school?
- Sarah Meibusch studied at Australian Institute of Company Directors (Graduate of the Australian Company Directors Course (GAICD)); Harvard Business School (Executive Education Program, Negotiation and Competitive Decision Making); Cornell University (Master's degree, Genome Sciences/Genomics cattle).
Same school
Also attended Australian Institute of Company Directors137
John DysonInvestment Principal at Starfish VenturesHelen SounessVenture Partner at RampersandTim HeasleyPartner at ArtesianKirsten BernhardtPrincipal at ArtesianJordan JeffreyPrincipal at ArtesianStephanie MorrisPrincipal at Artesian
+ 131 more
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesTim DraperFounder of Draper AssociatesMamoon HamidPartner at Kleiner PerkinsNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of Payhawk
+ 1,994 more
Also attended Cornell University748
Doug LeonePartner at Sequoia Capital; former Global Managing PartnerJenny LeeSenior Managing Partner at Granite AsiaNeeraj AgrawalGeneral Partner at Battery VenturesJohn ZimmerCo-founder of LyftMichelle FernandesInvestor at Index VenturesMicah RosenbloomGeneral Partner at Founder Collective
+ 742 more
Also attended The University of Queensland117
Giuseppe IademarcoHead of Global Partnership at P101 VenturesJasmine BettesInvestor at Reinventure GroupEsther GilmoreGlobal Head of the Client Team at Generation Investment ManagementNilay ThakarPrincipal at ARCH Venture PartnersZenetta BurgerPartner at Giant Ventures Global LlpCherie ChouHead of Corporate Development at TNBAura
+ 111 more
Shared employers
Also worked at OneVentures11
Joel BreuerAssociate at Level EquityMichelle DeakerFounding Partner and Managing Director at OneVenturesPaul KellyFounding Partner and Director at OneVenturesJustine CarzinoInvestment Director at OneVenturesNick GainsleyPartner at OneVenturesBevin ShieldsPartner at OneVentures
+ 5 more
Also worked at Vertero Therapeutics, Inc.4
Also worked at Queensland Alliance for Agriculture and Food Innovation (QAAFI)1
Also worked at Shire Pharmaceuticals13
Sun AltbachSenior Scientific Advisor at BOLD LongevityJulie KimRepresentative Director – President and CEO at Takeda VenturesGabriele RicciChief Data & Technology Officer at Takeda VenturesRamy RiadPresident, Plasma-Derived Therapies Business Unit at Takeda VenturesJeffrey M. JonasPartner at Cure VenturesSun AltbachSenior Advisor BOLD Longevity at Bold Capital Partners
+ 7 more